Keywords: درمان ضد تهاجمی دوگانه; antithrombotic therapies; valve replacement; valvular heart disease; AF; atrial fibrillation; BHV; biological heart valve; CI; confidence interval; DAPT; dual antiplatelet therapy; f; factor; INR; international normalized ratio; MHV; mechanical heart valv
مقالات ISI درمان ضد تهاجمی دوگانه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان ضد تهاجمی دوگانه; ACC/AHA; American College of Cardiology/American Heart Association; ACS; acute coronary syndrome; ADP; adenosine diphosphate; AF; atrial fibrillation; BRIGHT; Bivalirudin in Acute Myocardial Infarction vs Heparin and GPI Plus Heparin Trial; CAD; coronary
Keywords: درمان ضد تهاجمی دوگانه; Intestinal bleeding; Intra-aortic balloon pumping; Acute myocardial infarction; Dual antiplatelet therapy;
Keywords: درمان ضد تهاجمی دوگانه; Antiplatelet therapy; Personalized antiplatelet therapy; Endovascular interventions; Dual antiplatelet therapy; Platelet reactivity testing; Thrombocyte aggregation inhibitors
Keywords: درمان ضد تهاجمی دوگانه; Dual antiplatelet therapy; Drug-eluting stents; Percutaneous coronary intervention;
Keywords: درمان ضد تهاجمی دوگانه; anticoagulant agent(s); atrial fibrillation; stroke prevention; thromboembolism; AF; atrial fibrillation; CT; computed tomography; DAPT; dual antiplatelet therapy; EP; electrophysiologist; FDA; U.S. Food and Drug Administration; IC; interventional cardio
Keywords: درمان ضد تهاجمی دوگانه; bare-metal stents; drug-eluting stents; dual antiplatelet therapy; stent thrombosis
Keywords: درمان ضد تهاجمی دوگانه; antiplatelet therapy; aspirin; coronary stent; drug-eluting stent; P2Y12 inhibitors; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); CAD; coronary artery disease; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); L-DAPT; long duratio
Keywords: درمان ضد تهاجمی دوگانه; anticoagulation; atrial fibrillation; stroke; ACS; acute coronary syndrome(s); AF; atrial fibrillation; DOAC; direct-acting oral anticoagulant; DAPT; dual antiplatelet therapy; FFP; fresh frozen plasma; ICH; intracranial hemorrhage; INR; international n
Keywords: درمان ضد تهاجمی دوگانه; Clopidogrel; Drug-drug interaction; Dual antiplatelet therapy; Platelet reactivity;
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndromes; AIC; Akaike Information Criterion; BMI; body mass index; BSA; body surface area; CAG; coronary angiography; CYP; cytochrome P450; DAPT; dual antiplatelet therapy; DL; dyslipidemia; DNA; deoxyribonucleic acid; Hct; hematocrit
Keywords: درمان ضد تهاجمی دوگانه; 16; 23; 38; ADP; adenosine diphosphate; APT; antiplatelet therapy; BOCLA-Plan; BOchum CLopidogrel and Aspirin Plan; CABG; coronary artery bypass grafting; CI; confidence interval; CYP; cytochrome P450; dAPT; dual antiplatelet therapy; HR; hazard ratio; hR
Keywords: درمان ضد تهاجمی دوگانه; ACS; CABG; Surgery revascularization; Dual antiplatelet therapy; Ticagrelor; Clopidogrel;
Keywords: درمان ضد تهاجمی دوگانه; platelet aggregation inhibitors; graft occlusion; coronary artery bypass; saphenous vein grafts; dual antiplatelet therapy; coronary artery bypass grafting
Keywords: درمان ضد تهاجمی دوگانه; acenocoumarol; clopidogrel; dual antiplatelet therapy; oral anticoagulation; phenprocoumon; platelet aggregationACS, acute coronary syndrome(s); AF, atrial fibrillation; BARC, Bleeding Academic Research Consortium; DAPT, dual antiplatelet therapy; LMWH, l
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndrome; ADP; adenosine diphosphate; GPI; glycoprotein IIb/IIIa receptor inhibitor; MEA; multiple electrode aggregometry; NSTEMI; Non-ST-elevation myocardial infarction; PCI; percutaneous coronary intervention; STEMI; ST-elevation myo
Keywords: درمان ضد تهاجمی دوگانه; bare-metal stent(s); drug-eluting stent(s); stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); FDA; Food and D
A unique case of ST-elevation myocardial infarction related to very late stent thrombosis
Keywords: درمان ضد تهاجمی دوگانه; Drug-eluting stent; Optical coherence tomography; Dual antiplatelet therapy;
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
Keywords: درمان ضد تهاجمی دوگانه; bioresorbable scaffold; thrombosis; BRS; bioresorbable stent(s); BVS; Bioresorbable Vascular Scaffold; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MLD; minimum lumen diameter; QCA; quantitative coronary angiography; RVD; reference vessel
PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention
Keywords: درمان ضد تهاجمی دوگانه; ABCB1; ATP-binding cassette, sub-family B, member 1; ACEI; angiotensinconverting enzyme inhibitor; ADP; adenosine diphosphate; ARB; angiotensin receptor blocker; CCB; calcium channel blockers; CHD; Coronary Heart Disease; CLP; clopidogrel; CLPM; clopidogr
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT
Keywords: درمان ضد تهاجمی دوگانه; ACS; Acute coronary syndrome; CP; Clopidogrel period; DAPT; Dual antiplatelet therapy; DES; Drug-eluting stent; HBR; High bleeding risk; MI; Myocardial infarction; NACCE; Net adverse clinical and cerebral events; PCI; Percutaneous coronary intervention; T
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Keywords: درمان ضد تهاجمی دوگانه; cardiovascular outcomes; coronary disease; platelet; CABG; coronary artery bypass graft; CI; confidence interval; CV; cardiovascular; DAPT; dual antiplatelet therapy; HR; hazard ratio; ICH; intracranial hemorrhage; KM; Kaplan-Meier; MACE; major adverse ca
Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina
Keywords: درمان ضد تهاجمی دوگانه; chronic refractory angina; coronary sinus reducer; optimal medical therapy; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CCS; Canadian Cardiovascular Society; CS; coronary sinus; DAPT; dual antiplatelet therapy; IQR; interquartile
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Keywords: درمان ضد تهاجمی دوگانه; Antithrombotic; Anticoagulation; Antiplatelet; Surgery; Antitrombótico; Anticoagulación; Antiagregación; CirugÃa; AF; atrial fibrillation; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; DOAC; direct oral anticoagulant; PCI; percutaneous cor
Critical Appraisal of the 2018 ACC Scientific Sessions Late-Breaking Trials From a Statistician's Perspective
Keywords: درمان ضد تهاجمی دوگانه; clinical trials; conference presentations; critical appraisal; CHD; coronary heart disease; DAPT; dual antiplatelet therapy; MACE; major adverse cardiovascular events; MI; myocardial infarction; NSTEMI; non-ST-segment elevation myocardial infarction; oG
The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation
Keywords: درمان ضد تهاجمی دوگانه; Transcatheter aortic valve implantation; Bleeding complications; Platelet reactivity assessment; Implantation de valve aortique transcathéter; Complications hémorragiques; Ãvaluation de la réactivité plaquettaire; ARU; aspirin reaction units; AUC; ar
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the Fr
Keywords: درمان ضد تهاجمی دوگانه; Antiplatelet therapy; Surgery; Haemorrhage; Thrombosis; Local anaesthesia; Agent antiplaquettaire; Chirurgie; Hémorragie; Thrombose; Anesthésie loco-régionale; ADP; adenosine diphosphate; CABG; coronary artery bypass graft; DAPT; dual antiplatelet ther
The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndrome; ACT; activated clotting time; ADP; adenosine diphosphate; AHA/ACC; American Heart Association American/College of Cardiology; APTT; activated partial thromboplastin time; AVM; arteriovenous malformation; BID; twice daily; CAB
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - “Real World” Experience
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndrome; AF; atrial fibrillation; BARC; bleeding academic research consortium; CAD; coronary artery disease; CHA2DS2-VASc; congestive heart failure, hypertension, ageâ¯â¥â¯75p years (doubled), diabetes mellitus, prior stroke or TIA
CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han
Keywords: درمان ضد تهاجمی دوگانه; CAD; coronary artery disease; ACS; acute coronary syndrome; DAPT; dual antiplatelet therapy; PCI; percutaneous coronary intervention; SNPs; single nucleotide polymorphisms; LD; loading dose; MD; maintain dose; PRI; platelet reaction index; HTPR; high on-t
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
Keywords: درمان ضد تهاجمی دوگانه; ACC; American College of Cardiology; ACS; Acute Coronary Syndrome; ACT; Activated Clotting Time; AF; Atrial Fibrillation; AHA; American Heart Association; aPCC; Activated Prothrombin Complex Concentrate; aPTT; Activated Partial Thromboplastin Time; CAD; C
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
Keywords: درمان ضد تهاجمی دوگانه; ACE-I; angiotensin-converting-enzyme inhibitors; ACS; acute coronary syndrome; ARB; angiotensin receptor blocker; CABG; coronary artery bypass grafting; CI; confidence interval; CHF; congestive heart failure; DAPT; dual antiplatelet therapy; DES; drug elu
Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician
Keywords: درمان ضد تهاجمی دوگانه; ACC; American College of Cardiology; ACS; Acute coronary syndromes; AHA; American Heart Association; BMI; Body mass index; BMS; Bare metal stents; CAD; Coronary artery disease; CI; Confidence interval; CKD; Chronic kidney disease; CV; Cardiovascular; DAPT
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndrome; ACCOAST trial; Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pretreatment at the Time of Diagnosis in Patients with Non-ST Elevation Myocardial Infarction trial; ACUITY; acute catheterization
Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial
Keywords: درمان ضد تهاجمی دوگانه; antiplatelet drugs; coronary disease; coronary artery bypass graft; BITA; bilateral internal thoracic arteries; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CASCADE; Clopidogrel After Surgery for Coronary Artery Disease; CCTA; coro
DAPT Duration After Drug-Eluting Stent Implantation
Keywords: درمان ضد تهاجمی دوگانه; bleeding event(s); drug-eluting stent(s); dual antiplatelet therapy; ischemic event(s); percutaneous coronary intervention;
Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia
Keywords: درمان ضد تهاجمی دوگانه; ACS; acute coronary syndrome; BARC; bleeding academic research consortium; BMS; bare metal stent; DAPT; dual antiplatelet therapy; DES; drug eluting stent; GP IIb-IIIa; glycoprotein IIb-IIIa receptors; ICU; intensive cardiac unit; LVEF; left ventricle eje
Thrombocytopenia associated with TAVI-The summary of possible causes
Keywords: درمان ضد تهاجمی دوگانه; AS; aortic valve stenosis; BCMD; blood contacting medical devices; DAPT; dual antiplatelet therapy; DIC; disseminated intravascular coagulation; ES; Edwards Sapien; FS; Freedom Solo; F1+2; prothrombin fragments 1+2; GP; platelet glycoprotein; HIT; heparin
CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions
Keywords: درمان ضد تهاجمی دوگانه; Bleeding; VerifyNow Analyzer; CRUSADE score; Dual antiplatelet therapy; Prediction;
Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study
Keywords: درمان ضد تهاجمی دوگانه; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; EES; everolimus eluting stent; ISA; incomplete stent apposition; LAISA; late acquired incomplete stent apposition; OCT; optical coherence tomography; PES; paclitaxel eluting stent; PCI; percutaneou
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
Keywords: درمان ضد تهاجمی دوگانه; ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; DAPT; Dual antiplatelet therapy; HRPR; High-residual on treatment platelet reactivity; ASA; Acetylsalycilic acid; DES; Drug-eluting stents; CAD; Coronary artery disease; ADP; Adenosine
Coronary Artery Bypass Graft Surgery Using the Radial Artery, Right Internal Thoracic Artery, or Saphenous Vein as the Second Conduit
Keywords: درمان ضد تهاجمی دوگانه; BIMC; Beth Israel Medical Center; BITA; bilateral internal thoracic artery; CABG; coronary artery bypass graft surgery; CI; confidence interval; DAPT; dual antiplatelet therapy; HR; hazard ratio; LAD; left anterior descending artery; LITA; left internal t
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)
Keywords: درمان ضد تهاجمی دوگانه; Stent thrombosis; Bleeding risk; Dual antiplatelet therapy; Amphilimus eluting stent;
Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry - POL-TAVI
Keywords: درمان ضد تهاجمی دوگانه; Transcatheter aortic valve implantation; Bleeding; Vascular complications; Dual antiplatelet therapy;
Original ArticleSafety and Efficacy of a 600-mg Loading Dose of Clopidogrel 24 Hours Before Pipeline Embolization Device Treatment
Keywords: درمان ضد تهاجمی دوگانه; Aneurysm; Bolus; Clopidogrel; Loading dose; Pipeline Embolization Device; CI; Confidence interval; DAPT; Dual antiplatelet therapy; mRS; Modified Rankin Scale; OR; Odds ratio; PCI; Percutaneous coronary intervention; PED; Pipeline Embolization Device; PRU
Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent
Keywords: درمان ضد تهاجمی دوگانه; Stent; Endothelialization; Healing; COBRA PzF stent; Polyzene-F; Stent; Endothalization; Guérison; COBRA PzF stent; Polyzène-F; BMS; bare-metal stent; CABG; coronary artery bypass graft; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; NSTEMI;
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry
Keywords: درمان ضد تهاجمی دوگانه; ACC/AHA; American College of Cardiology/American Heart Association; DAPT; dual antiplatelet therapy; DES; drug eluting stents; LM/pLAD; left main/proximal left anterior descending artery; MACE; major adverse cardiac events; MI; myocardial infarction; PARI
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: درمان ضد تهاجمی دوگانه; restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry
Keywords: درمان ضد تهاجمی دوگانه; Drug-eluting stent; Dual antiplatelet therapy; Major adverse cardiac and cerebral events;
“Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)
Keywords: درمان ضد تهاجمی دوگانه; OCT; optical coherence tomography; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; LMWH; low molecular weight heparin; NSTEMI; non ST-segment elevation myocardial infarction; PROTECT-OCT; Prospective Registry of Cancer Patients with Coronary Ste